You are about to leave Helsinn's Corporate US Website.

Please click 'Continue to external site' if you want to continue.

News and Events

News

24 June 2021

Lugano, Switzerland, June 24, 2021 – Helsinn, a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically investing in a […]

28 May 2021

Pivotal study demonstrated a clinically meaningful rate of tumor shrinkage (overall response rate) and duration of response in patients with previously-treated advanced cholangiocarcinoma (CCA) harboring […]

27 May 2021

May 27, 2021 – Taiho Pharmaceutical Co., Ltd.  and Helsinn Healthcare SA, which is headquartered in Lugano, Switzerland , announced today that Taiho has acquired […]

29 April 2021

Lugano, Switzerland, April 29, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to announce […]

21 April 2021

Lugano, Switzerland, April 21, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, today announces the first […]

13 April 2021

Lugano, Switzerland, April 13, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to announce […]

31 March 2021

BridgeBio, through its Affiliate QED (“BridgeBio”), and Helsinn to co-commercialize infigratinib for oncology and all other indications other than skeletal dysplasia indications in the U.S. […]

23 March 2021

Lugano, Switzerland, March 23, 2021 – Helsinn Group (Lugano, Switzerland; CEO: Riccardo Braglia, “Helsinn”) is pleased to announce that its Japanese partner Taiho Pharmaceutical Co., […]

18 March 2021

Lugano, Switzerland, March 18, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to note […]

18 February 2021

Lugano, Switzerland, February 18, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to note […]

View all news articles

Events

No events currently available